You may have to Search all our reviewed books and magazines, click the sign up button below to create a free account.
This latest volume in the Harvey Lectures Series reflects "the evolution of physiology and physiological chemistry into biochemistry and the development of molecular biology from the roots of bacteriology and biochemistry" in the 20th and 21st centuries. This lecture series, collected and published annually, provides a series of distinguished lectures in the life sciences by world-renowned scientists in all areas of biomedicine. These lectures occur in New York City throughout the course of each academic year.
Hearing on concerns arising from the interstate transportation of human pathogens. Very dangerous, deadly organisms which cause diseases and death in human beings are available for purchase across State lines not only by those with a legitimate use for them, but by anyone else. These organisms include the agents that cause the bubonic plague, anthrax, and other diseases. The Federal Government has less stringent regulations on their transport than on the transport of pathogens causing disease in plants and animals. Some of the biological agents may be usable as weapons of mass destruction by terrorists and access to them should be regulated.
Distributed to some depository libraries in microfiche.
The Harvey Society was founded in 1905 by thirteen New York scientists and physicians with the purpose of forging a "closer relationship between the purely practical side of medicine and the results of laboratory investigation." The Society distributes scientific knowledge in selected areas of anatomy, physiology, pathology, bacteriology, pharmacology, and physiological and pathological chemistry through public lectures, which are published annually. Series 94, 1998-1999 covers themes in neurogenetic studies, the role of tyrosine phosphorylation in cell growth and disease, the biology of the epidermis and its appendages, and the phenotypic diversity of monogenic disease.
Human gene therapy holds great promise for the cure of many genetic diseases. In order to achieve such a cure there are two requirements. First, the affected gene must be cloned, its se quence determined and its regulation adequately characterized. Second, a suitable vector for the delivery of a good copy of the affected gene must be available. For a vector to be of use several attributes are highly desirable: these include ability to carry the intact gene (although this may be either the genomic or the cDNA form) in a stable form, ability to introduce the gene into the desired cell type, ability to express the introduced gene in an appropriately regulated manner for an extended period of ti...